New York S 6180: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Status: REFERRED TO INSURANCE (as of 2022-01-05)

State: New York · Session: 2021-2022 · Bill: S 6180

Sponsors: LANZA

View New York S 6180 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.